As of 2025-10-18, the Relative Valuation of Theravance Biopharma Inc (TBPH) is 3.65 USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.04 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -74.0%.
The range of the Relative Valuation is 1.99 - 7.15 USD.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 20.2x | 8.3x |
| Forward P/E multiples | 14.7x - 27.6x | 19.9x |
| Fair Price | 1.99 - 7.15 | 3.65 |
| Upside | -85.8% - -49.1% | -74.0% |
| Date | P/E |
| 2025-10-16 | 54.26 |
| 2025-10-15 | 53.72 |
| 2025-10-14 | 53.53 |
| 2025-10-13 | 53.80 |
| 2025-10-10 | 54.07 |
| 2025-10-09 | 56.08 |
| 2025-10-08 | 55.81 |
| 2025-10-07 | 55.46 |
| 2025-10-06 | 56.35 |
| 2025-10-03 | 55.69 |
| 2025-10-02 | 54.38 |
| 2025-10-01 | 55.73 |
| 2025-09-30 | 56.42 |
| 2025-09-29 | 55.77 |
| 2025-09-26 | 54.38 |
| 2025-09-25 | 53.29 |
| 2025-09-24 | 54.30 |
| 2025-09-23 | 54.38 |
| 2025-09-22 | 54.38 |
| 2025-09-19 | 53.64 |
| 2025-09-18 | 55.92 |
| 2025-09-17 | 54.30 |
| 2025-09-16 | 53.60 |
| 2025-09-15 | 55.65 |
| 2025-09-12 | 55.26 |
| 2025-09-11 | 52.95 |
| 2025-09-10 | 52.71 |
| 2025-09-09 | 53.18 |
| 2025-09-08 | 53.80 |
| 2025-09-05 | 53.91 |
| 2025-09-04 | 54.30 |
| 2025-09-03 | 53.08 |
| 2025-09-02 | 53.49 |
| 2025-08-29 | 53.64 |
| 2025-08-28 | 53.99 |
| 2025-08-27 | 53.33 |
| 2025-08-26 | 53.33 |
| 2025-08-25 | 53.31 |
| 2025-08-22 | 53.76 |
| 2025-08-21 | 52.79 |
| 2025-08-20 | 51.75 |
| 2025-08-19 | 51.98 |
| 2025-08-18 | 52.60 |
| 2025-08-15 | 50.82 |
| 2025-08-14 | 50.01 |
| 2025-08-13 | 48.00 |
| 2025-08-12 | 46.07 |
| 2025-08-11 | 44.06 |
| 2025-08-08 | 44.52 |
| 2025-08-07 | 43.32 |